DNA methylation biomarkers in RCC and their underlying mechanism
Biomarker | Sample | Method of diagnosis | Mechanism | Reference |
---|---|---|---|---|
VHL | Blood | Restriction endonuclease qPCR | VHL promoter methylation inactivates the VHL tumor suppressor gene which in turn regulates HIF protein and hence contributes to RCC carcinogenesis | [29, 38] |
RASSF1A | Blood | Restriction endonuclease qPCR; MSP | Hypermethylation of the RASSF1A promoter inactivates the RASSF1A tumor suppressor gene involved in DNA repair, cell cycle, and cell death | [39] |
PCDH17 | Urine, serum, and tissue samples | Quantitative MSP | PCDH methylation was linked to the downregulation of the PCDH17 tumor suppressor gene that functions through the regulation of cell-to-cell adhesion, growth control, and signal transduction PCDH17 hypermethylation was linked to progression and shorter disease-free survival in RCC patients | [39, 40] |
NEFH | Tissue | RNA expression microarray | DNA methylation of NEFH promoter and loss of expression has been linked to the AKT/β-catenin pathway leading to increased glycolysis rates and changes in the mitochondria | [41] |
APC | Urine and blood | Quantitative MSP | APC promoter methylation and subsequent loss of expression of the APC gene have been associated with nuclear β-catenin accumulation and p53 deficiency | [42] |
CDKN2A (p16) | Urine, blood, and tissue | Quantitative MSP | CDKN2A methylation plays an important role in RCC metastasis by affecting the p16/p14 expression | [43] |
MGMT | Blood, urine, and tissue | Quantitative MSP | Promoter methylation of MGMT inhibits the MGMT DNA repair gene | [44] |
TIMP3 | Blood, urine, and tissue | Quantitative MSP; restriction endonuclease qPCR | Methylation-associated silencing of TIMP3 has been associated with the acquisition of tumorigenesis as TIMP3 contributes to VEGF-mediated angiogenesis regulation | [45] |
ZNF677 | Blood, urine, and tissue | Methylated RNA immunoprecipitation-sequencing (MeRIP-seq) and MeRIP-qPCR | Promoter methylation of ZNF677 leads to ZNF677 silencing which functions as a tumor suppressor | [46] |
qPCR: quantitative PCR; MSP: methylation specific PCR; AKT: v-akt murine thymoma viral oncogene homolog
The authors are grateful to the Department of Biotechnology, Himachal Pradesh University, Shimla, for the providing various resources. We are also thankful to the Department of Biotechnology, Government of India, for providing the necessary support to the authors.
SG: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. SSK: Validation, Supervision.
The authors declare that there are no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2023.